Trump’s Muslim ban is building walls around science

Not just the info technology business within the U.S.A. and  India, but even leaders of the biotechnology business ar afraid by the visa and travel restrictions the Trump administration has unleashed.
Both sectors thrive on innovation and new concepts, and depend on the flow of talent from round the world. This free flow in these industries has helped the US attain a leadership position, catalysing local development and growth in different countries.
Most of the research and development (R&D) and innovation in the life sciences business is world. New ideas and technologies may emerge in one country, take shape in another and find application somewhere else. This sector thrives on start-ups, which are a key part of the value chain. Many big corporations are constantly scouting for innovation from start-ups around the world, bringing the potential ones over and integrating them into larger projects.
New product development can take place simultaneously across continents. It’s in this backdrop that leaders of the biotech industry have written an open letter against the visa ban to President Trump in the scientific journal Nature Biotechnology.
While the travel ban covers only seven Muslim countries, the letter points out that it’s already causing a ripple effect on people from other countries as well.
The letter points out that the US has greatly benefited from foreign nationals. More than half of the 69,000 biomedical researchers in the US were born outside. Researchers, clinicians, entrepreneurs and business executives from all over the world are responsible for the driving economic growth and employment provided in the sector.